A “Frist”-hand View of Health Care
Former US Senate majority leader Bill Frist, MD, sits down with CLP to discuss what personalized medicine will mean for labs.
Read More
Search Results for: liver disease
NEJM Reports Xpert MTB/RIF Faster, Sensitive & Specific Test for TB
Cepheid announced that its Xpert MTB/RIF test was the subject of a study published in the latest edition of the New England Journal of Medicine (NEJM), “Rapid Molecular Detection of Tuberculosis and Rifampin Resistance.”
Read More
Positives and Negatives
A look at the advantages and disadvantages of current respiratory virus testing methodologies.
Read MoreAbbott Molecular, Inc. Receives FDA Approval for First Automated Molecular Test for Assessing Hepatitis B Treatment
Abbott announced it has received approval from the U.S. Food and Drug Administration (FDA) to market the Abbott RealTime HBV assay for measuring viral load or the amount of hepatitis B virus (HBV) in a patient’s blood.
Read MoreInoLife Technologies to Market a Plavix Metabolizing Test to the Medical Industry
InoLife Technologies announced it will provide and market a proprietary metabolizing test to physicians and practitioners to identify how a patient’s genetic makeup may affect the body’s response to Plavix (colpidogrel).
Read More